← Open Payments lookup

NORMAN CHAZIN: Open Payments

NPI 1710970553 · LINWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$709 in 30 payments from 7 companies in 2025. Trend: 2023 $642 · 2024 $825 · 2025 $709

Food & beverage: $709
CompanyPaymentsAmount
ABBVIE INC.9$254
E.R. Squibb & Sons, L.L.C.5$180
Otsuka America Pharmaceutical, Inc.5$91
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$82
Lundbeck LLC3$48
Alkermes, Inc.2$35
Axsome Therapeutics, Inc.1$19

Products named: VRAYLAR, COBENFY, REXULTI, CAPLYTA, ABILIFY ASIMTUFII, Auvelity, LYBALVI, ARISTADA.

Industry payments across NJ — which companies pay providers there.